# Banco Vida Corp. – FDA Inspection, Sep 18, 2019

Source: https://www.keypedia.com/records/fda_inspections/banco-vida-corp/b7c6b6b6-81a9-45ca-93ab-50970e27ba52
Source feed: FDA_Inspections

> FDA inspection 1102161 of Banco Vida Corp., September 18, 2019. Classification: Official Action Indicated (OAI). 4 citations under 21 CFR part 1271. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102161
- Company Name: Banco Vida Corp.
- Inspection Date: 2019-09-18
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 4
- Enforcement Type: WARNING_LETTER

## Related Documents

- FDA Inspection 1337074 - 2026-09-16
- [FDA Inspection 1149817 - 2021-08-12](https://www.keypedia.com/records/fda_inspections/banco-vida-corp/511591a1-e5b6-4dde-84f8-6364eb6d3ac8)
- FDA Inspection 1036677 - 2017-12-07
- FDA Inspection 980721 - 2016-07-01

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/annette-melendez/bc1a065d-6408-4c4b-9dcf-c6884e8a75c4)
- [FDA Associated Person](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)

Company: https://www.keypedia.com/companies/banco-vida-corp/6710f827-76c1-4157-8a90-93c6458c3eca

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d